16785142

Doldi N

2006

Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.

16785157

Engin-Ust?n Y

2006

Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?

16785158

Palomba S

2006

Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age.

16785159

Yilmaz M

2006

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.

16785260

De Leo V

2006

Metformin treatment is effective in obese teenage girls with PCOS.

16789634

Claahsen-van der Grinten HL

2006

Fertility in patients with congenital adrenal hyperplasia.

16790094

Franks S

2006

Genetic and environmental origins of obesity relevant to reproduction.

16790096

Pasquali R

2006

Metabolic effects of obesity on reproduction.

16790098

Davies MJ

2006

Evidence for effects of weight on reproduction in women.

16790100

Moran LJ

2006

Effects of lifestyle modification in polycystic ovarian syndrome.

16790101

Redman LM

2006

Physical activity and its effects on reproduction.

16790102

Gleicher N

2006

An evolutionary concept of polycystic ovarian disease: does evolution favour reproductive success over survival?

16792841

Ulloa-Aguirre A

2006

Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance.

16793784

Al-Inany H

2006

Drugs for anovulatory infertility in polycystic ovary syndrome.

16793958

M?hlig M

2006

The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome.

16793959

Macut D

2006

Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.

16798273

Taylor AE

2006

Gonadotropin dysfunction in women with polycystic ovary syndrome.

16798274

Dunaif A

2006

Insulin resistance in women with polycystic ovary syndrome.

16798275

Franks S

2006

Candidate genes in women with polycystic ovary syndrome.

16798276

Legro RS

2006

Type 2 diabetes and polycystic ovary syndrome.

16798277

Essah PA

2006

Metabolic syndrome in women with polycystic ovary syndrome.

16798279

Orio F

2006

Cardiovascular risk in women with polycystic ovary syndrome.

16798280

Lobo RA

2006

Choice of treatment for women with polycystic ovary syndrome.

16798281

Ib??ez L

2006

Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.

16798282

Palomba S

2006

Ovulation induction in women with polycystic ovary syndrome.

16798283

Pasquali R

2006

Insulin-sensitizing agents in women with polycystic ovary syndrome.

16798285

Moghetti P

2006

Use of antiandrogens as therapy for women with polycystic ovary syndrome.

16798286

de Zegher F

2006

Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome.

16798287

Sultan C

2006

Clinical expression of polycystic ovary syndrome in adolescent girls.

16798288

Carmina E

2006

Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.

16798289

Magoffin DA

2006

Ovarian enzyme activities in women with polycystic ovary syndrome.

16804036

Mehta RV

2006

The effect of androgen blockade on granulosa cell estradiol production after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome.

16806206

Lee EJ

2006

Single nucleotide polymorphism in exon 17 of the insulin receptor gene is not associated with polycystic ovary syndrome in a Korean population.

16807225

Alexandraki K

2006

Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.

16807276

ESHRE Capri Workshop Group.

2006

Hormones and cardiovascular health in women.

16809378

Elia E

2006

The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice.

16816057

Dokras A

2006

Obstetric outcomes after in vitro fertilization in obese and morbidly obese women.

16817087

Lilja AE

2006

Polycystic ovary syndrome and metformin in pregnancy.

16817088

Walch K

2006

Impaired glucose tolerance is associated with changes in clinical and biochemical parameters in women with polycystic ovary syndrome.

16817091

Kimura F

2006

Mutational analysis of the follistatin-related gene in women with premature ovarian failure and polycystic ovary syndrome.

16817095

Trolle B

2006

The impact of physical activity in a case of polycystic ovary syndrome.

16817429

Takakura K

2006

[Hypermenorrhea (menorrhagia) and dysmenorrhea].

16817431

Iwashita M

2006

[Polycystic ovarian syndrome].

16817432

Takeuchi T

2006

[Hirsutism].

16817821

Draper N

2006

Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome.

16817823

Topcu S

2006

Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance.

16819763

Podnar S

2006

Non-neurogenic urinary retention (Fowler's syndrome) in two sisters.

16820113

Christiansen OB

2006

Future directions of failed implantation and recurrent miscarriage research.

16820958

Honnma H

2006

Altered expression of Fas/Fas ligand/caspase 8 and membrane type 1-matrix metalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats.

16821212

Olszanecka-Glinianowicz M

2005

[Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].

16821219

Ska?ba P

2005

[The metabolic aspects of polycystic ovarian syndrome].

16821220

Skrzypulec V

2005

[Sexual dysfunctions in selected endocrinopathies].

16821227

Krzysiek J

2005

[The principles and the routes of progestagenes' administration in PCOS].

16821451

Dekkers OM

2006

[Acne vulgaris: endocrine aspects].

16824296

Elmasry K

2006

Ovarian cancer aetiology: facts and fiction.

16825684

Moran LJ

2006

Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome.

16827765

Zhu WJ

2006

Transvaginal, ultrasound-guided, ovarian, interstitial laser treatment in anovulatory women with clomifene-citrate-resistant polycystic ovary syndrome.

16827766

Lord J

2006

The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial.

16827825

Pasquali R

2006

The impact of obesity on reproduction in women with polycystic ovary syndrome.

16828411

Essah PA

2006

Dermatology of androgen-related disorders.

16831357

Zhao JL

2006

[Epidemiological study of clinical characteristics of Chinese Han ethnic women with polycystic ovary syndrome].

16831358

Zhang EH

2006

[Features of morphometry of ultrasound and endometrial histology in the anovulatory polycystic ovary syndrome women].

16832314

Correll CU

2006

Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents.

16834985

Yang ZW

2006

[Treatment of polycystic ovary syndrome by tonifying kidney and promoting blood circulation].

16835214

Palomba S

2006

Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study.

16835536

Banning M

2006

Symptoms and treatments of polycystic ovary syndrome.

16839844

Vgontzas AN

2006

Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.

16848893

Revelli A

2006

Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.

16849400

Dewailly D

2006

Oligoanovulation with polycystic ovaries but not overt hyperandrogenism.

16849416

Goodarzi MO

2006

Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.

16856423

Sawathiparnich P

2005

Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS.

16857887

Fatemi HM

2006

Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.

16859124

Shi XB

2006

[Clinical analysis of 4 treatments for woman polycystic ovarian syndrome with infertility].

16860272

Legato MJ

2006

Gender-specific care of the patient with diabetes: review and recommendations.

16862066

Krstevska B

2006

Metformin improves menstrual patterns, endocrine and metabolic profile in obese hyperinsulinemic women with a polycystic ovary syndrome.

16864149

Naess?n S

2006

Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.

16868051

Stewart DR

2006

Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity.

16868063

Gambineri A

2006

Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.

16868149

Glintborg D

2006

Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.

16871362

Jun JK

2006

Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET.

16873041

Nicoletti A

2006

Paradigm shift.

16873802

Lo JC

2006

Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study.

16879826

Gilbert C

2006

Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis.

16880018

Lipton MG

2006

Women living with facial hair: the psychological and behavioral burden.

16880229

San Mill?n JL

2006

The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women.

16882267

Eroglu D

2006

Metabolic disorders in patients with recent gestational diabetes mellitus.

16882750

Murphy MK

2006

Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome.

16883081

Demissie YN

2006

Spontaneous singleton and twin pregnancy in two patients with polycystic ovary syndrome and type 2 diabetes following treatment with metformin combined with rosiglitazone.

16886591

Glueck CJ

2006

Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.

16886951

Barber TM

2006

Obesity and polycystic ovary syndrome.

16889184

Pekhlivanov B

2006

[Use of yasmin in the treatment of women with polycystic ovary syndrome].

16890553

Zhu W

2006

Ovarian interstitial YAG-laser: an effective new method to manage anovulation in women with polycystic ovary syndrome.

16890572

Berria R

2006

Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.

16891296

Boomsma CM

2006

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.

16892490

Cagnacci A

2006

Oral contraceptives and insulin sensitivity.

16893644

Roy P

2006

Determination of androgen bioactivity in human serum samples using a recombinant cell based in vitro bioassay.

16895960

Mortensen M

2006

Functional significance of polycystic-size ovaries in healthy adolescents.

16899578

Lima MH

2006

Up-regulation of the phosphatidylinositol 3-kinase/protein kinase B pathway in the ovary of rats by chronic treatment with hCG and insulin.

16900227

Bruner B

2006

Effects of exercise and nutritional counseling in women with polycystic ovary syndrome.

16903840

Balen AH

2006

The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility.